In COVID-19 survivors, the frequencies of CD5+ B cells demonstrated a two-fold increase compared to patients with a favorable outcome in the acute stage of the disease but were significantly lower when compared to patients with a poor disease outcome (Figure 4E). Here, CD5 is linked to COVID-19.